CVR: 44512971
Gefjon Pharma ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Thomas Frees Buthler, Anders Miki Bojesen and Torben Hald. The company's owners include Copenhagen Equity ApS, North2k ApS and TBU Holding 2023 ApS.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med udvikling, produktion og salg af lægemidler til levnedsmiddelindustrien samt enhver anden aktivitet, som efter ledelsens skøn står i forbindelse hermed.
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationScreen owners and management against the Danish FSA's official PEP lists
Contact info changed: new phone: 50899528, new email: [email protected], new website: www.gefjonpharma.com (June 12, 2026).
As of June 10, 2026, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Gefjon Pharma ApS.
Contact info changed: new phone: 50899528, new email: [email protected], new website: www.gefjonpharma.com (February 4, 2026).
As of February 3, 2026, Thomas Frees Buthler has joined the board of directors of Gefjon Pharma ApS.
As of February 3, 2026, Anders Miki Bojesen has joined the board of directors of Gefjon Pharma ApS.
As of February 3, 2026, Torben Hald has joined the board of directors of Gefjon Pharma ApS.
As of February 3, 2026, Fabio Antenucci has joined the board of directors of Gefjon Pharma ApS.
Gefjon Pharma ApS has published its interim report for the period December 19, 2023 – March 31, 2025.
As of January 27, 2025, Thomas Frees Buthler is registered as director of Gefjon Pharma ApS.
As of January 27, 2025, Anders Miki Bojesen is registered as director of Gefjon Pharma ApS.
As of January 27, 2025, Fabio Antenucci is registered as director of Gefjon Pharma ApS.
As of September 23, 2024, Thomas Frees Buthler has stepped down as director of Gefjon Pharma ApS.
As of September 1, 2024, Torben Hald is registered as adm. dir. of Gefjon Pharma ApS.
As of December 19, 2023, Thomas Frees Buthler is registered as director of Gefjon Pharma ApS.
As of December 19, 2023, Copenhagen Equity ApS is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
As of December 19, 2023, North2k ApS is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
As of December 19, 2023, TBU Holding 2023 ApS is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
As of December 19, 2023, is registered as an owner of Gefjon Pharma ApS with an ownership share of 25%.
Gefjon Pharma ApS was founded on December 19, 2023.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
companydata.dk